Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.
Department of Urology, All India Institute of Medical Sciences, Rishikesh, India.
Eur Urol. 2021 Aug;80(2):213-221. doi: 10.1016/j.eururo.2020.09.044. Epub 2020 Oct 14.
A common side effect following radical prostatectomy is urinary incontinence. Here, we describe a novel surgical technique to reduce postoperative urinary incontinence and facilitate early return of continence.
To describe the novel "hood technique" for robotic-assisted radical prostatectomy (RARP).
DESIGN, SETTING, AND PARTICIPANTS: This is an institutional review board-approved prospective study of 300 patients (median age 64 yr) with localized prostate cancer treated with the RARP hood technique at a major urban hospital between April 2018 and March 2019. The exclusion criteria were as follows: patients with anterior tumor location based on biopsy or multiparametric magnetic resonance imaging. All but one patient participated in follow-up over 12 mo after the procedure.
The RARP "hood technique" was performed to preserve the detrusor apron, puboprostatic ligament complex, arcus tendineus, endopelvic fascia, and pouch of Douglas.
Clinical data collected included pre- and intraoperative variables, and postoperative functional and oncological outcomes and complications. Descriptive statistical analysis was performed.
Continence rates at 1, 2, 4, 6 12, 24, and 48 wk after catheter removal were 21%, 36%, 83%, 88%, 91%, 94%, and 95%, respectively. Positive surgical margin rate was 6%. Thirty patients (9.7%) experienced complications after RARP: 17 (5.7%), 11 (3.6%), and one (0.4%) had Clavien-Dindo grade I, II, and III complications, respectively. This study was conducted within a single health system and may not be generalizable. The study lacked randomization and a comparative arm.
Results indicate that the hood technique spares musculofascial structures anterior to the urethral sphincter complex with early return of continence after surgery, without compromising positive surgical margin rates. Exclusion of anterior tumor location contributed to a reduction in positive surgical margins.
By better preservation of anatomical structures around the urethra, we were able to achieve early return of urinary continence without a negative impact on complications and cancer outcomes.
根治性前列腺切除术后的常见副作用是尿失禁。在这里,我们描述了一种新的手术技术,以减少术后尿失禁并促进早期恢复控尿能力。
描述机器人辅助根治性前列腺切除术 (RARP) 的新“罩技术”。
设计、地点和参与者:这是一项机构审查委员会批准的前瞻性研究,纳入了 2018 年 4 月至 2019 年 3 月在一家主要城市医院接受 RARP 罩技术治疗的 300 名局限性前列腺癌患者(中位年龄 64 岁)。排除标准如下:基于活检或多参数磁共振成像的患者存在前肿瘤位置。除 1 例患者外,所有患者在术后 12 个月后均参与随访。
进行 RARP“罩技术”以保留逼尿肌围裙、耻骨前列腺韧带复合体、弧形腱膜、盆内筋膜和Douglas 袋。
收集的临床数据包括术前和术中变量,以及术后功能和肿瘤学结果和并发症。进行描述性统计分析。
导管拔除后 1、2、4、6、12、24 和 48 周时的控尿率分别为 21%、36%、83%、88%、91%、94%和 95%。切缘阳性率为 6%。30 名患者(9.7%)在 RARP 后发生并发症:17 名(5.7%)、11 名(3.6%)和 1 名(0.4%)分别发生 Clavien-Dindo Ⅰ级、Ⅱ级和Ⅲ级并发症。本研究在单一医疗系统内进行,可能不具有普遍性。该研究没有随机分组和对照组。
结果表明,罩技术在不影响切缘阳性率的情况下,通过更好地保护尿道括约肌复合体周围的肌肉筋膜结构,实现术后早期恢复控尿。排除前肿瘤位置有助于降低切缘阳性率。
通过更好地保护尿道周围的解剖结构,我们能够在不影响并发症和癌症结果的情况下,早期恢复尿控。